Brief: Cosmo And Glenmark Announce Market Authorisation Of Winlevi 10 Mg/G Cream
01/12/2025 15:26
Dec 1 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS: COSMO AND GLENMARK ANNOUNCE MARKET AUTHORISATION OF WINLEVI® (CLASCOTERONE) 10 MG/G CREAM FOR TREATMENT OF ACNE IN 17 COUNTRIES IN EUROPE Source text: ID:nPreJbmtra Further company coverage: GLEN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter